Can platelet purinergic receptors be targeted to safely treat non-thrombotic diseases?
-
Chair(s):
Clive Page,
Professor of Pharmacology,King's College London, London, United KingdomDingxin Pan,
Postdoctoral Fellow,King's College London, London, United Kingdom -
Session description:
Platelet activation during inflammation and evidence for biased signalling via P2Y1
Dr Simon Pitchford
Reader in Immunopharmacology, King's College London, London, United KingdomThe role of the platelet P2Y12 receptor in inflammation
Professor Robert Storey
Professor of Cardiology, University of Sheffield, Sheffield, United KingdomOral communication speaker - to be confirmed in 2023
The Role of P2Y1 and P2Y14 receptors in non-thrombotic platelet functions
Kate Arkless
King's College London, United KingdomProbing P2Y1, P2Y12 and P2Y14 receptors with novel ligands and their potential therapeutic use
Dr Kenneth A. Jacobson
Senior Investigator, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, USASponsored by
Speakers
-
Dr Simon PitchfordReader In Immunopharmacology, King's College London, London, United Kingdom
-
Kate ArklessKing's College London United Kingdom, London, United Kingdom
-
Professor Kenneth A. JacobsonSenior Investigator, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, USA
-
Professor Robert StoreyProfessor of Cardiology, University of Sheffield, Sheffield, United Kingdom
Leave A Comment